Biotech China 2014

Cancer Biology: University of Texas, MD Anderson

Total Score People Score Events Score
243 170 110
Date Event Presentation Speakers
July 3, 2014 Calcium Signaling: from basic to bedside Presenilins, store operated calcium entry and synaptic loss in AD Ilya Bezprozvanny
April 11, 2014 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) Rakesh Kumar
March 5, 2014 Targeted Anticancer Therapies Preclinical Models in the Development of Cancer Therapeutics Lee M Ellis
January 30, 2014 Genitourinary Cancers Symposium A Decade in Review: Prostate Cancer Deborah Kuban
January 23, 2014 T-cell Lymphoma Forum T-cell Lymphoma Forum Madeleine Duvic
January 6, 2014 AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer Concurrent Sessions 3-4 John D Minna, Roy S. Herbst
Concurrent Sessions 1-2 John V Heymach, Ignacio I. Wistuba, Garth Powis
Plenary Session 2: Clinical Trial Design and Master Protocols Roy S. Herbst, J. Jack Lee
Opening Session Roy S. Herbst
October 28, 2013 Tumor Immunology and Immunotherapy TNFalpha and TLR3/4 induced necrosis pathway Xiaodong Wang
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Using Neurofibromatosis to model Cancer: therapeutic insights Luis F Parada
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Biochemical Characterization of Nucleic Acid Sensors in Dendritic Cells Yong-Jun Liu
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium The Practical Use of Molecular Profiling – Ballroom A Lajos Pusztai, Peter M. Ravdin
William L. McGuire Memorial Lecture – Exhibit Hall D Neoadjuvant System Therapy: Promising Experimental Model, or Improved Standard of Care? Gabriel N Hortobagyi
Mini-Symposium 2 - Exhibit Hall D Breast Density: Mechanisms and Clinical Implications Melissa L Bondy
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer P53 Guillermina Lozano
January 21, 2012 Melanoma 2012: 22nd Annual Cutaneous Malignancy Update Sentinel Node Evaluation Part II Merrick I Ross
Sentinel Node Evaluation Part I Merrick I Ross
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Genomic alterations in gingivobuccal cancer: Results from whole-exome resequencing Sadhan Majumder
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation Raymond N DuBois
Plenary Session 5 | Cancer Prevention and Chemoprevention Raymond N DuBois
Day in Review Raymond N DuBois
Session 4 | Molecular Epidemiology of Cancer: Towards Personalized Risk Assessment, Prevention, and Therapy Xifeng Wu
December 1, 2011 9th International Conference on Ovarian Cancer Novel imaging for Ovarian Cancer Homer A. Macapinlac
Secondary Surgical Cytoreduction Pedro T. Ramirez
Session III | Surgery Debates Robert L. Coleman
Use of Biomarkers to Personalize Care for Epithelial Ovarian Cancer Robert C Bast
Angiogenesis Inhibitors in Clinical Practice Robert L. Coleman
November 18, 2011 16th Annual Perspectives In Thoracic Oncology New insights in the management of mesothelioma Anne Tsao
November 15, 2011 Cosa 38th Annual Scientific Meeting Management of Ta and T1 bladder cancer Michael Wallace
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Cancer interception and reverse migration Scott M Lippman
Educational Session 1 | Treatment of Premalignant Conditions Scott M Lippman
Novel agents for epigenetic therapy Jean-Pierre Issa
Is there a role for metformin in cancer therapeutics? Ana Gonzalez-Angulo
October 10, 2011 15th Annual Meeting Collaborative Group of the Americas, on Inherited Colorectal Cancer (CGA-ICC) Hot Topics | Basic Science C. Richard Boland
Improving Endoscopic Identification of Colorectal Neoplasms in Hereditary Colon Cancer Syndromes Patrick M Lynch
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease Dynamics and dimerization in TGF-beta signal transduction Andrew P. Hinck
August 7, 2011 Mobile DNA in Mammalian Genomes Comparative genomics of mammalian mobile elements Cedric Feschotte
Session 7 | Mobile Element Evolution Cedric Feschotte
July 30, 2011 MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management Non-Small Cell Lung Cancer | Combined Modality Therapy for Patients with Stage II/III Disease Scott M Lippman
Making Sense of Multigene Assays in Practice Ana Gonzalez-Angulo
HER-2 Directed Therapies: Adjuvant or Neoadjuvant? Ana Gonzalez-Angulo
Challenging Case Presentations and Interactive Audience Participation Deborah Kuban
Dose Escalation and Stereotactic Therapy in the Management of Pancreatic Cancer Sunil Krishnan
Active Surveillance vs. Treatment in the Management of Prostate Cancer Deborah Kuban
Molecular Markers Guiding Diagnosis and Optimizing Management of Leukemias Stefan Faderl
Emerging Paradigms in the Management of Myeloproliferative Disorders Stefan Faderl
New Therapeutic Targets in Lymphoma | The B-cell Receptor, CD-30 Fredrick B Hagemeister
PET Scan in Lymphoma: Which Histologies? When? Can it Guide Treatment? Fredrick B Hagemeister
Advances in RT: IMRT, Short Course and Selective Omission of RT Sunil Krishnan
July 6, 2011 3rd WIN Symposium CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Committee on standardization of biobanking and molecular analyses of biopsies in clinical trials (open to the public) STANLEY HAMILTON, Ignacio I. Wistuba
ROUND TABLE - PANEL OF EXPERTS - FORUM OF OPEN DISCUSSION WITH ATTENDEES | Monotherapies or combined therapeutics? Clinically addressing the complexity of molecular pathways in cancer: How can we develop the most relevant combination beyond individual Pharma/Biotech pipelines: a risk sharing approach for the benefit of the patient JOHN MENDELSOHN
KEYNOTE LECTURE | Challenges and opportunities in personalized cancer therapy and cooperation between the Pharmaceutical Industry and Academia. The WIN Consortium model and operational goals JOHN MENDELSOHN
SESSION 4 | STRATEGIC ALLIANCES TO FIGHT CANCER JOHN MENDELSOHN
Using biomarkers prospectively in adaptive trials Donald Berry
SESSION 7 | STRATEGIES TO IMPROVE EFFICIENCY OF CLINICAL TRIALS Donald Berry
CONCURRENT WORKSHOPS | Workshop of the WIN Consortium Scientific Committee on the design of clinical trials, data processing and access (open to the public) Razelle Kurzrock, Donald Berry
CONCLUSION | THE URGENT NEED FOR INCREASED ACCESS OF PATIENTS FROM DIVERSE POPULATIONS TO INNOVATIVE CLINICAL TRIALS JOHN MENDELSOHN
General Assembly of the WIN Consortium (business meeting, restricted to members and open to non members by request and invitation only) JOHN MENDELSOHN
June 30, 2011 2011 AHPBA Americas Post Graduate Course Session 2 | Future Perspectives on Treatment Sequencing for Hepatocellular Carcinoma Steven A Curley
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis MicroRNA-200 | A Sensor of the Extracellular Milieu and Regulator of Metastasis Jonathan M. Kurie,
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Characterization of new post-transcriptional regulators of fatty acid synthesis Jay Horton
April 29, 2011 8th CURRENT TRENDS IN AORTIC AND CARDIOTHORACIC SURGERY Antegrade or Retrograde Perfusion in Arch Repair | Which One—or Both? Anthony L. Estrera
April 4, 2011 RNAi & Single Cell Biology-2011 Summit TBA Alex Bishop
The role of microRNAs in Vegf signaling, and angiogenesis David Lawson
March 27, 2011 Congress on Steroid Research Metabolic impact of sex hormones on obesity Deborah Joy Clegg
March 27, 2011 Autophagy (D1) Workshop 2: Autophagy and Disease: A Clinical Point of View Beth Levine
Autophagy and Exercise Beth Levine
March 9, 2011 28th Annual Miami Breast Cancer Conferenceâ„¢ Nipple Discharge and Gynecomastia Henry Kuerer
Histologic and Biologic Markers to Differentiate Indolent From Aggressive DCIS Henry Kuerer
Is There a Role for Preoperative Therapy in DCIS? Henry Kuerer
Session B | Can We Personalize Adjuvant Chemotherapy? William F. Symmans
Predicting Survival From Adjuvant Therapy William F. Symmans
Breast Cancer Brain Metastasis | "The Seed and the Soil" Isaiah J. Fidler
Session B | "Meet the Professor" Sessions William F. Symmans
Roundtable Discussion With Audience Participation on Current Issues in Breast Cancer | Follow-up, Treatment Side Effects, Costs, End-of-Life Care, and "Burn-Out" William F. Symmans
Biomarkers for Resistance in Residual Tumor William F. Symmans
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer Session 2 | PI3K Pathway Aberrations in Human Cancer Gordon Mills
mTORC1 regulation by TSC2 Cheryl Lyn Walker
Predictors and pharmacodynamic markers of rapamycin response Funda Meric-Bernstam
Session 4 | Targeting mTOR Funda Meric-Bernstam
Targeting the PI3K/AKT/mTOR pathway in the clinic: Early results from the PREDICT program Razelle Kurzrock
Session 8 | Novel PI3K/mTOR Pathway Inhibitors in Clinical Trials II Funda Meric-Bernstam
Overcoming challenges to targeting the PI3K pathway in cancer Gordon Mills
Molecular marker-based clinical trial designs to target the PI3K pathway Ana Gonzalez-Angulo
Session 7 | Novel PI3K/mTOR Pathway Inhibitors in Clinical Trials I Funda Meric-Bernstam
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma How I Manage Relapsed/Refractory Chronic Lymphocytic Leukemia William G. Wierda
Comment William G. Wierda
HDAC Function and HDAC Inhibitors: Where Is the Selectivity? Jean-Pierre Issa
Epigenetics and the Biology of Hematologic Malignancies Anas Younes
Afternoon Workshop | Epigenetics and Gene Expression Anas Younes
Comment Jean-Pierre Issa
The Nature of Future MoAbs in Leukemia William G. Wierda
Non-Hodgkin Lymphoma: Conjugated and Nonconjugated MoAbs Anas Younes
Chronic Lymphocytic Leukemia William G. Wierda
Acute Myeloid Leukemia | Myelodysplastic Syndromes Jean-Pierre Issa
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Harnessing the Cell Biology of Dendritic Cells against Cancer (Joint) | Plasmacytoid DC in Cancer Yong-Jun Liu
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Ligand-directed targeting and nanotechnology: Discovery and translational updates Renata Pasqualini
Targeted gold nanoparticles and non-invasive RF treatment for cancer Steven A Curley
Title to be announced Mauro Ferrari
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Interpretation of biomarker studies Lajos Pusztai
MicroRNA in medical practice George A. Calin
Cancers are stressed too: exploiting cancer stress for new therapies Garth Powis
December 1, 2010 European Colorectal Congress 2010 Radio-frequency ablation of hepatic metastases from colorectal cancer Abdalla Eddie K
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Professional Advancement Session Margaret R. Spitz
Proximity of personalized risk and predictive markers to the clinic Scott M Lippman
Plenary Session 1: Personalized Prevention Scott M Lippman
Efficient designs for lung cancer prevention trials: Lessons learned and moving forward J. Jack Lee
Report on AACR-NCI Think Tank: Charting the Future of Cancer Prevention Raymond N DuBois
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Chen Dong
October 27, 2010 Colorectal Cancer: Biology to Therapy Inflammation and cancer: Impact of COX-2 and other inflammatory mediators Raymond N DuBois
October 24, 2010 Frontiers in Tumour Progression Short Talk Lee M Ellis
October 19, 2010 Colon Cancer in Murine Models and Humans III SESSION 3: Genome (in)stability (CIN and MIN) and epigenetic factors (CIMP): The multiple pathway hypothesis; somatic mutations and epimutations | Bar Harbor Club Ballroom Jean-Pierre Issa, STANLEY HAMILTON
SESSION 5: Inflammation and environmental risk factors; intestinal flora; chemoprevention | Bar Harbor Club Ballroom Raymond N DuBois
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities Educational Session 2: The Chronic Disease Prevention Model: It's Time to Think Strategically Elisabeth Martinez
Quantitative epigenomics for epidemiology research Jean-Pierre Issa
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved The Chronic Disease Prevention Model: It's Time to Think Strategically Elisabeth Martinez
Quantitative epigenomics for epidemiology research Jean-Pierre Issa
September 27, 2010 Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development Session 2A: Molecular Markers and Patient Decisions Peter M. Ravdin
Session 1A: Emerging Role of Nanotechnology in Molecular Diagnostics Mauro Ferrari
Introductory Remarks Gordon Mills
Plenary Session 8: Molecular Marker Trial Design Roy S. Herbst
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Therapy of Cancer Metastasis: Attacking the Stroma Isaiah J. Fidler
The Biology of Cancer Metastasis Isaiah J. Fidler
September 13, 2010 Resveratrol2010 Chemosensation of resveratrol Bharat B. Aggarwal
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Special Presentation | Title to be announced S. Ward Casscells
The biology behind the successes and failures of VEGF-targeted therapies Lee M Ellis
Comparing genomics of primary tumors and metastases for targets identification and biomarkers development in lung cancer Ignacio I. Wistuba
August 24, 2010 Trends in Cancer Diagnostics - Early Detection and Optimum Therapy Molecular Expressions of Circulating Tumor Cells (CTCs) to Guide Targeted Cancer Therapies and Improve Patient Care Alexander L. Weis
Chairperson’s Remarks Alexander L. Weis
July 11, 2010 Translational Cancer Medicine 2010 (USA) Toward personalized therapy for advanced non-small cell lung cancer: The M. D. Anderson BATTLE Programs Roy S. Herbst
July 7, 2010 WIN Symposium in personalized cancer medicine Personalized targeted therapy in lung cancer: winning the battle and paradigm shift. Waun Ki Hong
Individualized prevention, early detection and treatment as ways to decrease cancer mortality and improve patient outcomes. JOHN MENDELSOHN
Welcome address JOHN MENDELSOHN
Next generation of biomarkers and tracers for increased diagnostic sensitivity of lung cancer. JURI GELOVANI
Integration of systems biology concepts into clinical trials. Lajos Pusztai
Breakthrough in individualized cancer treatment: innovative therapeutic developments (2) JOHN MENDELSOHN
Breakthrough in individualized cancer treatment: new scientific concepts and technological achievements (1) Ignacio I. Wistuba
Regulatory, financial and societal challenges of new technologies and methods Ignacio I. Wistuba
Open Interactive Forum JOHN MENDELSOHN
Keynote Lecture | Societal challenges of personalized medicine: STANLEY HAMILTON
June 6, 2010 The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities Educational Session 1: Biomarker Discovery for Epidemiological Studies Xifeng Wu
June 4, 2010 From Chronic Inflammation to Cancer Chronic inflammation and gene polymorphism C. Richard Boland
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Lipid-protein interactions as a determinant of membrane protein structure and function William Dowhan
Sterol analysis in mammalian cells and tissues David Russell
April 10, 2010 Practical Updates in Oncology Therapeutic Options in Ovarian Cancer Robert L. Coleman
Advances in Chronic Lymphocytic Leukemia William G. Wierda
Targeted Therapies for Gastrointestinal Malignancies Cathy Eng
Treatment Advances in SCLC and NSCLC Joan H Schiller
Lunch/Ethics Lecture Michael S Ewer
December 11, 2009 Santa Fe Gastrointestinal Cancer Conference Epidemiology of Biliary Tree Cancer Manal M Hassan
Management of GI Neuroendocrine Cancers James C. Yao
Predicting Tumor Response Cathy Eng
Management of Colorectal Cancer Cathy Eng
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Keynote Lecture: Whole Systems Research in Integrative Oncology: What is It? Why Do We Need It? Lorenzo Cohen
d. Massage Therapy Sat-Siri Sumler
Theory/Practice Moshe Frenkel
1) Preferred Abstracts (5) Basic Peiying Yang
Whole Systems Into Practice: Summary and Future Visions David I Rosenthal, Moshe Frenkel
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Sushovan Guha
Case Presentation 2: Locally Advanced (Radiotherapy vs. Chemotherapy) Gauri Varadhachary
Panel Discussion With Interactive Q/A Sushovan Guha
A Novel Small Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In Vivo Sushovan Guha
Prognostic Factors of Rectal and Anal Cancer Outcomes Prajnan Das
Panel Discussion With Interactive Q/A Ju-Seog Lee
Molecular Biology: East and West Ju-Seog Lee
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells The Clinical Utility of Circulating Tumor Cell Analysis: What Have We Learned So Far? Beverly C. Handy
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Personalized Medicine: Using Biomarker Signatures to Predict Response to New Therapies J. Kyle Wathen
September 23, 2009 Track 2: Implementing Personalized Medicine : Inaugural Personalized Medicine Personalized Medicine: Using Biomarker Signatures to Predict Response to New Therapies J. Kyle Wathen
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis Systems Approach to Biomarker Identification Gordon Mills
June 9, 2009 Cell and Tissue-Based Assays for HTS A Novel Platform for High-Throughput Gene Expression Profiling Andreas Jeromin
June 8, 2009 Genotyping Tools Rare Functional SNPs and the Genetic Architecture of Complex Diseases Ivan Gorlov
June 8, 2009 RNAi for Functional Screens Towards Functional Annotation of the Cancer Genome Michael A. White
February 7, 2009 Translation of the Cancer Genome SESSION 6: PRECLINICAL THERAPEUTICS Garth Powis
SESSION 7: TRANSLATIONAL MEDICINE Lajos Pusztai
February 3, 2009 Cancer Health Disparities PLENARY SESSION 2: INJECTING CULTURE INTO THE ATTACK ON CANCER Amelie G Ramirez
CONCURRENT SESSIONS M Kristen Peek
January 27, 2009 7th Annual Global Pricing and Reimbursement Congress Biosimilars pricing and the generics market Thomas A a Buchholz
January 21, 2009 Advances in Prostate Cancer Research SESSION 3: APOPTOSIS Xiaodong Wang
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Systems approach to personalized molecular medicine Gordon Mills
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Concurrent D: COMP-specific Ribozyme: A New Strategy for Gene Therapy Joseph Alcorn
Concurrent E: Modeling single and collective cell movements in 3D matrices Muhammad H. Zaman
Junior Investigator Awardee: Fibulins: Implications in Vascular Development and Disease Hiromi Yanagisawa
Concurrent H: Skeletal abnormalities in quad- KO mice (TSP1, 3, 5, and Col 9) Karen Posey,
Concurrent N: Postnatal Ablation of Sox9 in Mouse Cartilage Stephen Henry,
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Omega-3 Fatty Acids and Cancer Prevention Robert S. Chapkin
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow EPIGENETIC THERAPY IN MDS Hagop M. Kantarjian
THERAPY FOR POST-IMATINIB FAILURES Jorges Cortes
LUMILIXIMAB STUDIES IN CLL Susan O’Brien
MODIFIED DOCETAXEL-BASED REGIMENS FOR ADVANCED GASTROESOPHAGEAL CANCERS Jaffer , Ajani
INTRAVENOUS REOLYSIN IN BONE OR SOFT TISSUE SARCOMA METASTIC TO LUNG Monica M. Mita
ABIRATERONE ACETATE: AN ANDROGEN WITHDRAWAL RESPONSIVE PHENOTYPE IN CRPC Eleni Efstathiou
PERSONALIZED THERAPY APPROACHES FOR ADVANCED NSCLC Roy S. Herbst
AMG386: A FIRST-IN-CLASS ANGIOPOIETIN TARGETED THERAPY Alain C. Mita
October 30, 2008 44th ASCO Annual Meeting General Session IV: Molecular Markers of Response and Resistance to Angiogenesis Inhibitors John Heymach
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Workshop 1 Animal models in drug development J. L. Abbruzzese
Plenary session 10 Challenges in the development of anti bodies and antibody conjugates Chris H. Takimoto
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Crystallographic Studies of CYP46A1 Irina A. Pikuleva
September 5, 2008 44th ASCO Annual Meeting General Session I: Risk, Screening, and Prevention Melissa L Bondy
General Session VII: Challenges in Survivorship Janice Cormier
General Session X: Multidisciplinary Implications of Preoperative Therapy Funda Meric-Bernstam, Lajos Pusztai
May 30, 2008 44th ASCO Annual Meeting Program Committee Cathy Eng
Steering Commitee Robert S Bresalier, Steven A Curley
Steering Commitee Deborah Kuban
Program Committee Christopher G Wood
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
April 27, 2008 Phage Display of Antibodies and Peptides Engineering Aglycosylated Antibodies with Effector Functions George Georgiou
Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
March 25, 2008 PATHWAY ANALYSIS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
March 25, 2008 CANCER MOLECULAR MARKERS Non Coding RNAs Involvement in Cancer Predisposition and Tumor Development George A. Calin
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 3: DSB repair and its control (Chair: Joe Jiricny) Tanya Paull
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE The regulation of the real lymphatic function - lymph transport David Zawieja
GENETICS AND TREATMENT OF LYMPHATIC DISORDERS David Zawieja
February 12, 2008 NF-kappaB Regulation of the NF-kappaB Pathway Shao-Cong Sun
Signaling to NF-kappaB Zhijian James Chen, Xin Lin
Regulation of NF-kappaB and Chromatin Shao-Cong Sun
February 11, 2008 Stem Cells World Congress Expansion and Engineering of Cord Blood Stem Cells L Denner
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis PCSK9, a secreted protease with a non-protease function Jay Horton
February 3, 2008 AACR - Cytoskeletal Signaling in Cancer PLENARY TALK Rakesh Kumar
SESSION 1: CYTOSKELETON SIGNALING AND CANCER Rakesh Kumar
SESSION 4: HOT TOPICS: TALKS FROM ABSTRACTS Rakesh Kumar
SESSION 6: MIGRATION AND METASTASIS Rakesh Kumar
January 18, 2008 Translational Research Program Stem Cell Symposium Critique/Discussion Wendy Woodward
Circulating Tumor Cells Massimo Cristofanilli
Panel Discussion Luka Milas
January 6, 2008 AUTOPHAGY IN STRESS, DEVELOPMENT AND DISEASE Autophagy in stress, development and disease: past, present and future directions Beth Levine
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Muhammad H. Zaman
Cellular Biology of Gap Junction Channels (Room 103A) Guillermo Altenberg, Srikanth Polusani
Translocon-mediated Head-First Insertion and Rotation of a Signal Anchor during Cotranslational Integration. A E Johnson
Mechanism of the Neurospora Circadian Negative Feedback Loop. Yi Liu
November 29, 2007 Cell Signalling and Novel Cancer Therapeutics Key note Lecture - A systems biology approach to drug development and implementation Gordon Mills
November 17, 2007 Translational Therapies in Breast Cancer New Trends in Hormonal Therapies for Breast Cancer Aman Buzdar
On the Horizon: Novel Chemotherapeutic and Biologic Agents Marjorie Green
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
November 4, 2007 2007 International Symposium On Protein Modification And Degradation Session 4: Ubiquitin and Ubiquitin-like Proteins in Signaling Zhijian James Chen
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Genome Resequencing for Mutation Screening (13:30-18:30) George A. Calin
Genome Resequencing for Mutation Screening: Toward a Non-Coding RNA Revolution in the Cancer Society (14:50-15:20) George A. Calin
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) Carole R. Mendelson
NUCLEAR HORMONE RECEPTORS: Progesterone Receptor Modulation of Inflammatory Signaling in Pregnancy and Labor (17:20-17:50) Carole R. Mendelson
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Madeleine Duvic
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Madeleine Duvic
September 7, 2007 The 2007 Breast Symposium General Session IV: Clinical and Research Issues in Pathology 3:45 PM — 5:30 PM William F. Symmans
General Session V: Local Regional Management 8:00 AM — 9:45 AM Funda Meric Bernstam
Tyrosine-Kinase Inhibitors Francisco J. Esteva
Challenges for Radiation Therapy After Preoperative Therapy Thomas A a Buchholz
August 11, 2007 Gastrointestinal Tract XII: The Molecular and Integrative Basis for GI Development, Homeostasis and Disease Branch Aging & altered patterns of expression in the colon: A role for colonic stem cells? Mark Evers
August 11, 2007 Growth factor receptor tyrosine kinases in mitogenesis, morphogenesis Nuclear role for the EGFR and ERBB2 Mien-Chie Hung
August 4, 2007 Obesity, Energy Balance and Disease Calorie restriction, IGF-1, and cancer Stephen D Hursting
Obesity, insulin resistance and disease in children Michael I Goran
July 28, 2007 Nutritional Immunology: Its Role in Health and Disease Inhibition of autoimmunity and bone loss by n-3 fatty acids Gabriel Fernandes
Mechanisms of omega-3 fatty acid regulation of T-lymphocytes Christopher Jolly
N-3 PUFA, T-Cell inflammation and colon cancer David N McMurray
July 14, 2007 Skeletal Muscle Satellite & Stem Cells Foxk1 Represses FoxO Factors and Regulates Muscle Progenitor Cells Xiaozhong Shi
Foxk1 regulates the activation of muscle stem cells Daniel J Garry
Satellite Cells as the Rhabdomyosarcoma Cell of Origin Charles Keller
Increased myogenic progenitor cell accumulation in CCR2- /- mice despite bone marrow-dependent impairments in muscle regeneration and macrophage recruitment Paula K Shireman
July 7, 2007 CHROMATIN AND TRANSCRIPTION In vivo functions of histone modifying enzymes Sharon Dent
Mec1/Tel1 phosphorylation of the INO80 chromatin remodeling complex influences DNA damage checkpoint responses Xuetong Shen
TAP-ing into the p53-proteome Michelle Barton
July 7, 2007 Protein Kinases and Protein Phosphorylation Ubiquitin-mediated activation of TAK1 and IKK Zhijian James Chen
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Tissue Genesis and Repair Jacqueline T Hecht
Insights into COMP/TSP5 related causes of abnormal skeletogenesis Jacqueline T Hecht
June 9, 2007 Ion Channel Regulation Regulation by the phospholipid PIP2 Donald Hilgemann
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease The mechanochemistry of ABC Transporters Philip J Thomas
V-ATPases in cancer and angiogenesis Raul Martinez Zaguilan
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.